Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

19 Jul LGC acquires LINK and strengthens its oligo reagents offering

LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

25 May Designated Institute Annual Review 2016 now available

Reviews 2016 activities and highlights breadth and quality of our research

03 Apr LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

Moves strengthen existing analytical and bioanalytical drug development service offering

24 Nov LGC acquires BRC Global Standards

LGC expands its supply chain assurance offering, creating a new business unit within its Standards division to focus on this growing market

11 Nov LGC appoints Brian Kim Managing Director, Genomics

LGC announced that it has appointed Brian Kim as Managing Director, Genomics, leading the group’s international Genomics division.